________________________________________________________________________________________________________________________________________
© 2021.The Nemours Foundation.® Nemours is a registered trademark of The Nemours Foundation.
________________________________________________________________________________________________________________________________________
Monday, December 6, 2021
11:45 a.m. - 12:45 p.m.
Accredited VIRTUAL Symposium
In the NICU setting, birth defects or genetic conditions contribute to approximately 30% of admissions and nearly 40% of deaths. Many acutely ill infants do not present with stereotypic phenotypes specific to their condition, making a hypothesis-driven approach to diagnostic testing difficult. Additionally, the clinical picture of many acutely ill infants is complicated by many comorbidities (i.e., prematurity, birth trauma, and sepsis) making the development of an accurate phenotype-based differential diagnosis even more challenging.
With an increase in implementation of rapid WES/WGS as a first-tier test in the NICU/PICU setting, supporting evidence shows this diagnostic and prognostic tool offers dramatic increases in speed and efficiency, allowing for proper medical management of critically ill neonate patients.
Pre-Registration is not required for this symposium.
Evaluating the Value of Whole Genomic Sequencing in Critically ill Neonates
Presented by EXCEL Continuing Education
___________
_____________________________________________________________________________________________________________________________
